Enhancement of oral absorption in selective 5-HT1D receptor agonists:: Fluorinated 3-[3-(piperidin-1-yl)propyl]indoles

被引：25
|
作者：
Castro, JL
Collins, I
Russell, MGN
Watt, AP
Sohal, B
Rathbone, D
Beer, MS
Stanton, JA
机构：
[1] Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Dept Chem, Harlow CM20 2QR, Essex, England
[2] Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Dept Biochem, Harlow CM20 2QR, Essex, England
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 1998年 / 41卷 / 15期
关键词：
D O I：
10.1021/jm980204e
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：2667 / 2670
页数：4
相关论文
共 50 条
  • [31] (S)-3-(3-((7-Ethynyl-9H-pyrimido[4,5-b]indol-4-yl)amino)piperidin-1-yl)propanenitrile
    Andreev, Stanislav
    Plank, Nicole
    Schollmeyer, Dieter
    Koch, Pierre
    MOLBANK, 2022, 2022 (03)
  • [32] A 3D MODEL OF A SELECTIVE RECOGNITION SITE IN THE HUMAN 5-HT1D RECEPTOR
    SMOLYAR, A
    OSMAN, R
    BIOPHYSICAL JOURNAL, 1993, 64 (02) : A84 - A84
  • [33] Synthesis of aryl {4-[({5-[3-(methylsulfonyl)phenyl]pyrazin-2-yl}-oxy)methyl]piperidin-1-yl}methanones
    Sriramudu, B.
    Satyanarayana, B.
    Muralikrishna, P.
    Ramachandran, D.
    Journal of Chemical and Pharmaceutical Research, 2014, 6 (07) : 1873 - 1883
  • [34] 3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT6 receptor modulators
    Bernotas, Ronald C.
    Antane, Schuyler
    Shenoy, Rajesh
    Le, Van-Duc
    Chen, Ping
    Harrison, Boyd L.
    Robichaud, Albert J.
    Zhang, Guo Ming
    Smith, Deborah
    Schechter, Lee E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) : 1657 - 1660
  • [35] Propylpiperazines as high affinity and selective 5-HT1D agonists.
    Chambers, MS
    Graham, MI
    Hobbs, SC
    Jelley, R
    MacLeod, AM
    Matassa, VG
    Reeve, AJ
    Sohal, B
    Sternfeld, F
    Street, LJ
    Beer, M
    Stanton, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 46 - MEDI
  • [36] Synthesis and Antileukemic Activity of Novel 2-(4-(2,4-dimethoxybenzoyl)phenoxy)-1-(4-(3-(piperidin-4-yl)propyl)piperidin-1-yl)ethanone Derivatives
    Vinaya, Kambappa
    Kavitha, Chandagirikoppal V.
    Prasanna, Doddakunche S.
    Chandrappa, Siddappa
    Ranganatha, Somasagara R.
    Raghavan, Sathees C.
    Rangappa, Kanchugarakoppal S.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 79 (03) : 360 - 367
  • [37] Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide
    Trapella, Claudio
    Fischetti, Carmela
    Pela', Michela
    Lazzari, Ilaria
    Guerrini, Remo
    Calo', Girolamo
    Rizzi, Anna
    Camarda, Valeria
    Lambert, David G.
    McDonald, John
    Regoli, Domenico
    Salvadori, Severo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (14) : 5080 - 5095
  • [38] STRUCTURE OF 1-[3-(IMIDAZOL-1-YL)PROPYL]THYMINE
    GDANIEC, M
    WENSKA, G
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1986, 42 : 1604 - 1606
  • [39] In vitro assessment of the vascular effects of 5-HT1D-receptor agonists: Relationships with 5-HT1D alpha- or 5-HT1D beta-receptor binding affinity
    Shaw, D
    Stanton, JA
    Heald, MA
    Beer, MS
    Sternfeld, F
    Street, L
    Hill, RG
    Cooke, E
    Longmore, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 : P112 - P112
  • [40] (2E)-3-(3-Nitrophenyl)-1-[4-(piperidin-1-yl) phenyl] prop-2-en-1-one
    Fun, Hoong-Kun
    Chia, Tze Shyang
    Nayak, Prakash S.
    Narayana, B.
    Sarojini, B. K.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O974 - +
12345